TGFB1 and neoplasm: Overall, the data presented here reveal that KRASmut tumor activates TGFβ signaling to reduced proinflammatory and cytokine gene signatures, resulting in recruitment of immunosuppressive cells, including MSDS and T-reg in the TME.